Clinical and molecular profile of de novo vs. secondary EGFR mutated metastatic non-small-cell lung cancer

MLA

M. Faehling, et al. “Clinical and Molecular Profile of de Novo vs. Secondary EGFR Mutated Metastatic Non-Small-Cell Lung Cancer.” 61. Kongress Der Deutschen Gesellschaft Für Pneumologie Und Beatmungsmedizin e.V, Feb. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f859a1f3b23581bbb4a39bae8d8627d2&authtype=sso&custid=ns315887.

APA

M. Faehling, N. Magios, J. Kuon, Albrecht Stenzinger, Daniel Kazdal, Fjf Herth, Volker Endris, Michael Meister, Thomas Muley, Michael Thomas, Stefan Rieken, Helge Bischoff, Tilmann Bochtler, Harland S. Winter, Martina Kirchner, Anna-Lena Volckmar, Farastuk Bozorgmehr, Petros Christopoulos, C.P. Heussel, & J. Budczies. (2020). Clinical and molecular profile of de novo vs. secondary EGFR mutated metastatic non-small-cell lung cancer. 61. Kongress Der Deutschen Gesellschaft Für Pneumologie Und Beatmungsmedizin e.V.

Chicago

M. Faehling, N. Magios, J. Kuon, Albrecht Stenzinger, Daniel Kazdal, Fjf Herth, Volker Endris, et al. 2020. “Clinical and Molecular Profile of de Novo vs. Secondary EGFR Mutated Metastatic Non-Small-Cell Lung Cancer.” 61. Kongress Der Deutschen Gesellschaft Für Pneumologie Und Beatmungsmedizin e.V, February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f859a1f3b23581bbb4a39bae8d8627d2&authtype=sso&custid=ns315887.